Salud financiera de hoja de balance de AcroMeta Group

Salud financiera controles de criterios 1/6

AcroMeta Group tiene un patrimonio de los accionistas total de SGD1.7M y una deuda total de SGD5.8M, lo que sitúa su ratio deuda-patrimonio en 346%. Sus activos y pasivos totales son SGD31.8M y SGD30.1M respectivamente.

Información clave

346.0%

Ratio deuda-patrimonio

S$5.81m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	S$4.94m
Patrimonio	S$1.68m
Total pasivo	S$30.14m
Activos totales	S$31.82m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (SGD23.5M) de 43F no cubren sus pasivos a corto plazo (SGD26.3M).

Pasivo a largo plazo: Los activos a corto plazo de 43F (SGD23.5M) superan a sus pasivos a largo plazo (SGD3.8M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 43F (51.7%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de 43F ha crecido de 42.4% a 346% en los últimos 5 años.

Cobertura de la deuda: El flujo de caja operativo de 43F es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 43F sobre su deuda están bien cubiertos por el EBIT.

Salud financiera de hoja de balance de AcroMeta Group

Salud financiera controles de criterios 1/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

New minor risk - Financial data availability

New major risk - Share price stability

AcroMeta Group Limited Announces Appointment of Pan Congxian, Jeremy as the Financial Controller Effective 15 October 2024

AcroMeta Group Limited Announces Resignation of Cheah Lai Min as Chief Financial Officer

Anton Setiawan acquired 67% stake in PT Acromec Trading Indonesia from AcroMeta Group Limited (Catalist:43F) for SGD 5000.

Executive Director recently bought S$53k worth of stock

High number of new and inexperienced directors

Acrometa Group Limited Appoints Toh Ker How as the Executive Director of the Company

An undisclosed buyer agreed to acquire 70% stake in Life Science Incubator Pte Ltd from AcroMeta Group Limited (Catalist:43F).

First half 2024 earnings released: S$0.007 loss per share (vs S$0.004 profit in 1H 2023)

AcroMeta Group Limited Announces Re-Designation of Lim Say Chin as Executive Director to Executive Chairman

Acrometa Group Limited Announces Resignation of Levin Lee Keng Weng as Executive Chairman

High number of new and inexperienced directors

AcroMeta Group Limited Announces Retirement of Chew Chee Keong as Executive Director, Effective 30 January 2024

Full year 2023 earnings released: EPS: S$0.036 (vs S$0.028 in FY 2022)

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2024

Full year 2023 earnings released: EPS: S$0.033 (vs S$0.012 in FY 2022)

New minor risk - Financial data availability

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

AcroMeta Group Limited has filed a Follow-on Equity Offering in the amount of SGD 0.5 million.

Acrometa Group Limited Appoints Cheah Lai Min as Chief Financial Officer

New minor risk - Share price stability

Acrometa Group Limited Announces Resignation of Tan Buck Kiang Jerry as Chief Financial Officer

AcroMeta Group Limited (Catalist:43F) completed the acquisition of additional 40% stake in Life Science Incubator Pte Ltd.

First half 2023 earnings released: EPS: S$0.004 (vs S$0.001 in 1H 2022)

Executive Chairman recently sold S$126k worth of stock

AcroMeta Group Limited (Catalist:43F) entered into a legally binding letter of intent to acquire additional 40% stake in Life Science Incubator Pte Ltd for SGD 1.6 million.

Acrometa Group Limited Appoints Cheong Keng Chuan, Alfred as Non-Executive and Lead Independent Director, Audit Committee Chairman and Member of the Nominating Committee and Remuneration Committee

Non-Executive Non-Independent Director recently sold S$56k worth of stock

Less than half of directors are independent

AcroMeta Group Limited Appoints Levin Lee Keng Weng as Executive Chairman and Director of the Board

AcroMeta Group Limited, Annual General Meeting, Jan 30, 2023

Acrometa Group Limited Announces Appointment of Mahtani Bhagwandas an Independent Director

Full year 2022 earnings released: EPS: S$0.012 (vs S$0.001 in FY 2021)

AcroMeta Group Limited Group Limited Announces Resignation of Elaine Beh Pur-Lin as Independent Director

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Acromec Limited Appoints John Geno-Oehlers as Independent Director, Member of the Audit, Remuneration and Nominating Committees

Acromec Limited Announces Expiry of Memorandum of Understanding

Full year 2020 earnings released: S$0.011 loss per share

Acromec Limited, Annual General Meeting, Jan 27, 2021

Acromec Limited to Report Fiscal Year 2020 Results on Nov 27, 2020

Acromec Limited (Catalist:43F) completed the acquisition of remaining 40% stake in Golden Harvest Engineering Pte Ltd from Liang Kum Keong and Quek Ghee Leong.

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera